Envoy Medical (COCH) Equity Average (2021 - 2026)

Envoy Medical has disclosed Equity Average across 6 years of filings, most recently posting -$998500.0 for Q1 2026.

• Equity Average for Q1 2026 came in at -$998500.0, up 95.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$998500.0 (up 95.36% YoY), and the FY2025 annual result was -$15.5 million, down 50.35% from the prior year.
• Equity Average came in at -$998500.0 for Q1 2026 at Envoy Medical, up from -$9.9 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.5 million in Q4 2023 to a low of -$46.3 million in Q2 2023.
• The 5-year median for Equity Average is -$20.2 million (2023), against an average of -$20.7 million.
• Across the five-year window, Equity Average surged 104.88% in 2023 and slumped 1342.03% in 2024, its largest moves.
• Envoy Medical's Equity Average stood at -$30.9 million in 2022, then soared by 104.88% to $1.5 million in 2023, then plunged by 1342.03% to -$18.7 million in 2024, then surged by 46.99% to -$9.9 million in 2025, then soared by 89.92% to -$998500.0 in 2026.
• The last three Equity Average figures came in at -$998500.0 (Q1 2026), -$9.9 million (Q4 2025), and -$18.8 million (Q3 2025), per Business Quant data.